NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the NAPLEX (North American Pharmacist Licensure Examination) Test. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What monitoring is essential after initiating treatment with a calcimimetic in a CKD patient?

  1. Hemoglobin levels

  2. Blood sugar levels

  3. Calcium levels

  4. Urine output

The correct answer is: Calcium levels

It is essential to monitor calcium levels after initiating treatment with a calcimimetic in a CKD patient because calcimimetics work by reducing the levels of parathyroid hormone, which can result in a decrease in blood calcium levels. Hemoglobin levels may also be important to monitor, but this is not the most essential parameter to keep an eye on. Blood sugar levels and urine output are not directly affected by calcimimetic treatment and therefore do not need to be specifically monitored for changes.